N/A
Completed N=628
Twitter and Diabetes
Source: ClinicalTrials.gov NCT02806700 ↗Enrolled (actual)
628
Serious AEs
—
Results posted
Oct 2024
Primary outcomePrimary: Change in Patient Activation Measure (PAM) Score From Baseline — 3.4; 0.0 score on a scale
Summary
Twitter use is surprisingly well represented across broad demographic population segments and health-related messages. The promise of using Twitter is that its use is growing rapidly, it allows the investigators to view communications that were impossible to intercept before, and it potentially provides information faster and less expensively than collection from other media channels. Prior work also supports that social media interventions can improve health behavior change (e.g. weight loss, physical activity) and outcomes.The overarching goals of this proposal are to understand the uses and limitations of this communication channel to improve patients' ability to manage their CV health condition.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Patient Activation Measure (PAM) Score From Baseline |
3.4; 0.0 | — |
| SECONDARY Change in Systolic Blood Pressure From Baseline |
-19.8; -18.5 | — |
Eligibility Criteria
Inclusion Criteria
- diabetes
- uses social media
Exclusion Criteria
- <21 years of age
- pregnant
Data sourced from ClinicalTrials.gov (NCT02806700). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.